Expert Opinion

Watch expert pathologists and oncologists discuss key issues in the diagnosis and molecular testing of lung cancer.

Benefit of rapid ROS1 testing
18 May 2017
Dr Sanjay Popat from The Royal Marsden discusses major advances in the field of NSCLC...
Which patients should be tested for ALK?
18 May 2017
Professor Federico Cappuzzo, IRST-AUSL della Romagna, Ravenna, Italy explains why cli...
ROS1 testing in patients
18 May 2017
Dr Tony Mok, The Chinese University of Hong Kong, describes factors that may impact R...
International guidelines on testing for A...
18 May 2017
Professor Federico Cappuzzo, IRST-AUSL della Romagna, Ravenna, Italy summarises inter...
How and when to test for ROS1 fusion 1
18 May 2017
Dr Fernando López-Ríos, University Hospital Sanchinarro, Madrid, discusses the opti...
Benefits of the ESP Quality Assessment Fo...
18 May 2017
Professor Els Dequeker, University of Leuven, discusses the origins and benefits of t...